Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
Envoy Medical, Inc. - Class A (COCH)
Company Research
Source: GlobeNewswire
During “The Claman Countdown,” the billionaire investor and entrepreneur noted how hearing aid modes in next-gen wireless earbuds can work with Envoy Medical’s fully implanted hearing devices WHITE BEAR LAKE, Minnesota, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: “COCH”), a hearing health company focused on fully implanted hearing systems, today highlights an interview with key investor Glen Taylor on Fox Business News “The Claman Countdown” in which he commented on the news that Apple’s new AirPods Pro 2 can be used as hearing aids. In the interview, Mr. Taylor was asked whether he was worried about Apple entering the hearing technology market, and he discussed how he believed it could be additive to Envoy Medical’s product offering. Mr. Taylor noted that due to Envoy Medical’s fully implanted devices taking in sound through the ear, devices like the AirPods Pro 2 could potentially work in concert with Envoy Medical’s fully impla
Show less
Read more
Impact Snapshot
Event Time:
COCH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COCH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COCH alerts
High impacting Envoy Medical, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
COCH
News
- Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss [Yahoo! Finance]Yahoo! Finance
- Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing LossGlobeNewswire
- Envoy Medical, Inc. (NASDAQ: COCH) had its price target raised by analysts at Ascendiant Capital Markets from $8.75 to $9.00. They now have a "buy" rating on the stock.MarketBeat
COCH
Analyst Actions
- 12/6/24 - Ascendiant Capital
COCH
Sec Filings
- 2/6/25 - Form SCHEDULE
- 1/21/25 - Form 424B5
- 1/21/25 - Form 8-K
- COCH's page on the SEC website